Barriers to integrating personalized medicine into clinical practice: a best–worst scaling choice experiment
暂无分享,去创建一个
Stirling Bryan | Marco Marra | Mehdi Najafzadeh | Larry D. Lynd | L. Lynd | M. Marra | S. Bryan | A. Anis | C. Marra | Jennifer C. Davis | M. Najafzadeh | Carlo A. Marra | Aslam Anis
[1] T. Peters,et al. Best--worst scaling: What it can do for health care research and how to do it. , 2007, Journal of health economics.
[2] J. Louviere,et al. Probabilistic models of set-dependent and attribute-level best-worst choice , 2008 .
[3] L. Lynd,et al. An Evaluation of Patients' Willingness to Trade Symptom-Free Days for Asthma-Related Treatment Risks: A Discrete Choice Experiment , 2008, The Journal of asthma : official journal of the Association for the Care of Asthma.
[4] R. Croyle,et al. Physician use of genetic testing for cancer susceptibility: results of a national survey. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[5] J. Louviere,et al. Some probabilistic models of best, worst, and best–worst choices , 2005 .
[6] R. Service. The Race for the $1000 Genome , 2006, Science.
[7] R. Croyle,et al. US physicians' attitudes toward genetic testing for cancer susceptibility , 2003, American journal of medical genetics. Part A.
[8] Mandy Ryan,et al. Bayesian and classical estimation of mixed logit: An application to genetic testing. , 2009, Journal of health economics.
[9] Jaekyu Shin,et al. Pharmacogenetics: from discovery to patient care. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[10] David A. Hensher,et al. A latent class model for discrete choice analysis: contrasts with mixed logit , 2003 .
[11] M Ryan,et al. Eliciting public preferences for healthcare: a systematic review of techniques. , 2001, Health technology assessment.
[12] Jordan J. Louviere,et al. Modeling the choices of individual decision-makers by combining efficient choice experiment designs with extra preference information , 2008 .
[13] T. Lumley,et al. Motivating factors for physician ordering of factor V Leiden genetic tests. , 2009, Archives of internal medicine.
[14] R. Gramling,et al. Predictive genetics in primary care: Expectations for the motivational impact of genetic testing affects the importance family physicians place on screening for familial cancer risk , 2003, Genetics in Medicine.
[15] R. Nussbaum,et al. Addressing the Challenges of the Clinical Application of Pharmacogenetic Testing , 2009, Clinical pharmacology and therapeutics.
[16] Paul G Shekelle,et al. Delivery of genomic medicine for common chronic adult diseases: a systematic review. , 2008, JAMA.
[17] Francis S Collins,et al. The genome gets personal--almost. , 2008, JAMA.
[18] M. Gantley,et al. Tensions between policy makers and general practitioners in implementing new genetics: grounded theory interview study , 1999, BMJ.
[19] Patricia Goodson,et al. Barriers to the provision of genetic services by primary care physicians: A systematic review of the literature , 2003, Genetics in Medicine.
[20] M. Ryan,et al. Using discrete choice experiments to value informal care tasks: exploring preference heterogeneity. , 2011, Health economics.
[21] L. Wilkins-Haug,et al. Obstetrician-gynecologists' opinions and attitudes on the role of genetics in women's health. , 2000, Journal of women's health & gender-based medicine.
[22] W. Grody,et al. Keeping up with the next generation: massively parallel sequencing in clinical diagnostics. , 2008, The Journal of molecular diagnostics : JMD.
[23] F. Takada,et al. Physicians' opinion for ‘new’ genetic testing in Japan , 2009, Journal of Human Genetics.
[24] B. Psaty,et al. Personalized medicine in the era of genomics. , 2007, JAMA.
[25] John D Potter,et al. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. , 2008, JAMA.
[26] G. Glendon,et al. Genetic susceptibility to cancer. Family physicians' experience. , 2003, Canadian family physician Medecin de famille canadien.
[27] E. Podolak. Sequencing's new race. , 2010, BioTechniques.
[28] Mark Gerstein,et al. Personal genome sequencing: current approaches and challenges. , 2010, Genes & development.
[29] D. Levy,et al. Primary care physicians' concerns about offering a genetic test to tailor smoking cessation treatment , 2007, Genetics in Medicine.
[30] M. Spitz,et al. Genetic susceptibility to cancer: ICRP Publication 79 , 1993, Cancer.
[31] J. Louviere,et al. Conducting Discrete Choice Experiments to Inform Healthcare Decision Making , 2012, PharmacoEconomics.
[32] Malorye Allison,et al. Is personalized medicine finally arriving? , 2008, Nature Biotechnology.
[33] M Ryan,et al. Using conjoint analysis to elicit preferences for health care , 2000, BMJ : British Medical Journal.
[34] K. Payne,et al. Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis , 2008, Genetics in Medicine.